v3.26.1
Share-Based Payments
6 Months Ended
Jul. 04, 2026
Share-Based Payments  
Share-Based Payments

(16)

Share-Based Payments

The following table details our stock option activity for the first two quarters of fiscal 2026 (dollars in thousands, except per share data):

Weighted

Weighted Average

Average

Contractual Life

Aggregate

  ​ ​ ​

Options

  ​ ​ ​

Exercise Price

  ​ ​ ​

Remaining (Years)

  ​ ​ ​

Intrinsic Value

Outstanding at January 3, 2026

 

2,106,193

$

20.33

 

6.56

$

20

Granted

 

189,111

$

3.99

 

Exercised

 

$

Forfeited

 

$

Expired

(62,251)

$

37.48

Outstanding at July 4, 2026

 

2,233,053

$

18.46

 

6.56

$

17

Exercisable at July 4, 2026

 

1,443,942

$

19.56

 

6.11

$

The fair value of the options was estimated on the date of grant using the Black-Scholes option-pricing model utilizing the following assumptions. Expected volatility was based on both historical and implied volatilities of our common stock over the estimated expected term of the award. The expected term of the options granted represents the period of time that options were expected to be outstanding and is generally based on the “simplified method” in accordance with accounting guidance. We generally utilize the simplified method to determine the expected term of the options as we do not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term. The risk-free interest rate for the expected term of options is based on the U.S. Treasury implied yield at the date of grant. The assumptions used in the Black-Scholes option-pricing model for options granted during the first two quarters of 2026 and 2025 were as follows:

  ​ ​ ​

2026

  ​ ​ ​

2025

Weighted average grant date fair value

$

0.87

  ​ ​ ​

$

0.41

Expected volatility

54.90%

53.77%

Expected term

5.5 years

5.5 years

Risk-free interest rate

1.7%

4.1%

Dividend yield

9.5%

18.3%

The following table details the activity in our performance share long-term incentive awards (LTIAs) for the first two quarters of 2026:

  ​ ​ ​

  ​ ​ ​

Weighted Average

Number of

Grant Date Fair Value

  ​ ​ ​

Performance Shares(1)

  ​ ​ ​ ​ ​

(per share)(2)

Outstanding at January 3, 2026

 

4,378,111

$

7.69

Granted

 

2,883,092

$

2.66

Vested

 

(743,341)

$

13.00

Forfeited

 

(845,155)

$

6.54

Outstanding at July 4, 2026

 

5,672,707

$

4.61

(1)Solely for purposes of this table, the number of performance shares is based on the participants earning the maximum number of performance shares (i.e., 300% of the target number of performance shares).
(2)The fair value of the awards was determined based upon the closing price of our common stock on the applicable measurement dates (i.e., the deemed grant dates for accounting purposes), reduced by the present value of expected dividends using the risk-free interest-rate, as the award holders are not entitled to dividends or dividend equivalents during the vesting period.

The following table details the activity in our restricted stock for the first two quarters of 2026:

  ​ ​ ​

  ​ ​ ​

Weighted Average

Number of Shares

Grant Date Fair Value

  ​ ​ ​

of Restricted Stock

  ​ ​ ​ ​ ​

(per share)(1)

Outstanding at January 3, 2026

 

1,055,670

$

8.58

Granted

 

948,747

$

5.12

Vested

 

(482,841)

$

9.58

Forfeited

 

(147,793)

$

6.24

Outstanding at July 4, 2026

 

1,373,783

$

6.09

(1)The fair value of the awards was determined based upon the closing price of our common stock on the applicable measurement dates (i.e., the deemed grant dates for accounting purposes).

The following table details the number of shares of common stock issued by our company during the second quarter and first two quarters of 2026 and 2025 upon the vesting of performance share LTIAs, the exercise of stock options, the issuance of restricted stock and other share-based compensation net of cancellations:

Thirteen Weeks Ended

Twenty-six Weeks Ended

  ​ ​ ​

July 4,

  ​ ​ ​

June 28,

  ​ ​ ​

July 4,

  ​ ​ ​

June 28,

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2026

  ​ ​ ​

2025

Number of performance shares vested

 

 

 

743,341

 

Shares withheld for tax withholding

 

 

 

(291,997)

 

Shares of common stock issued for performance share LTIAs

 

 

 

451,344

 

Shares of common stock issued to non-employee directors for annual equity grants

 

242,235

 

222,003

 

242,235

 

222,003

Shares of restricted common stock issued to employees

15,595

948,747

767,569

Shares of restricted stock withheld and cancelled for tax withholding upon vesting

(8,206)

(49)

(194,688)

(111,811)

Shares of restricted stock cancelled upon forfeiture

(139,730)

(4,517)

(147,793)

(7,236)

Net shares of common stock issued

 

109,894

 

217,437

 

1,299,845

 

870,525

The following table sets forth the compensation expense recognized for share-based payments (performance share LTIAs, restricted stock, stock options, non-employee director stock grants and other share-based payments) during the second quarter and first two quarters of 2026 and 2025 and where that expense is reflected in our consolidated statements of operations (in thousands):

Thirteen Weeks Ended

Twenty-six Weeks Ended

July 4,

June 28,

July 4,

June 28,

Consolidated Statements of Operations Location

2026

  ​ ​ ​

2025

  ​ ​ ​

2026

  ​ ​ ​

2025

Compensation expense included in cost of goods sold

$

497

$

429

$

838

$

824

Compensation expense included in selling, general and administrative expenses

 

2,444

 

2,954

 

4,940

 

5,730

Total compensation expense for share-based payments

$

2,941

$

3,383

$

5,778

$

6,554

As of July 4, 2026, there was $5.8 million of unrecognized compensation expense related to performance share LTIAs, which is expected to be recognized over the next 2.5 years, $7.3 million of unrecognized compensation expense related to restricted stock, which is expected to be recognized over the next 2.7 years, and $0.9 million of unrecognized compensation expense related to stock options, which is expected to be recognized over the next 1.6 years.